And worth mentioning again that this poor patient was Cohort 1 so on the lower dose, beginning on only 2mg/Kg so on a fifth of the dose that is now the recommended amount. The Graphs clearly showed that once the patients were changed from the lower doses up to the higher ones there was a big uptick in positive (slowing of progression) results. The quicker they can get patients on to the 10mg/KG of MPL the better results, unfortunately this patient had the quickest form of MND and was restricted to the lowest dose for the first part of the treatment. From now on at least all patients will go straight onto the higher dose.
- Forums
- ASX - By Stock
- The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
And worth mentioning again that this poor patient was Cohort 1...
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
-0.005(2.08%) |
Mkt cap ! $93.03M |
Open | High | Low | Value | Volume |
24.0¢ | 26.0¢ | 23.0¢ | $579.7K | 2.369M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 29999 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 79713 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 29999 | 0.235 |
2 | 193065 | 0.230 |
5 | 105388 | 0.225 |
7 | 223408 | 0.220 |
5 | 55744 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 79713 | 4 |
0.250 | 23920 | 5 |
0.255 | 1062460 | 3 |
0.260 | 311980 | 3 |
0.265 | 181000 | 2 |
Last trade - 16.10pm 12/06/2024 (20 minute delay) ? |
|
|||||
Last
23.5¢ |
  |
Change
-0.005 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
24.0¢ | 25.8¢ | 23.5¢ | 1174846 | ||
Last updated 15.54pm 12/06/2024 ? |
Featured News
PAA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online